Toxicity and Metabolism of Layered Double Hydroxide Intercalated with Levodopa in a Parkinson’s Disease Model

By Kura Aminu Umar   Ain Nooraini Mohd   Hussein Mohd Zobir   Fakurazi Sharida   Hussein-Al-Ali Samer Hasan  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-04 ,pp. : 5916-5927

MDPI

Access to resources Recommend Favorite

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

By Comi Cristoforo   Ferrari Marco   Marino Franca   Magistrelli Luca   Cantello Roberto   Riboldazzi Giulio   Bianchi Maria Laura Ester   Bono Giorgio   Cosentino Marco  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 242-242

MDPI

Access to resources Recommend Favorite

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar   Rosas-Hernandez Hector   Cuevas Elvis   Lantz Susan M.   Barger Steven W.   Sarkar Sumit   Paule Merle G.   Ali Syed F.   Imam Syed Z.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

By Fiandaca Massimo S.   Bankiewicz Krystof S.   Federoff Howard J.  

Pharmaceuticals, Vol. 5, Iss. 6, 2012-06 ,pp. : 553-590

MDPI

Access to resources Recommend Favorite

The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease

By Falk Torsten   Gonzalez Robert T.   Sherman Scott J.  

International Journal of Molecular Sciences, Vol. 11, Iss. 8, 2010-08 ,pp. : 2875-2900

MDPI

Access to resources Recommend Favorite